
Dr. Pradeep Kumar is a dedicated Consultant Orthopaedic Oncosurgeon specializing in Bone and Soft Tissue Cancers (Sarcomas). With qualifications including MBBS, MS (Ortho), DNB (Ortho), MNAMS, Fellowship in Joint Replacement, and Fellowship in MSK Oncology from Tata Memorial Centre (a unit of HBCH&RC), he brings over 10 years of rich experience in managing complex musculoskeletal tumors.
Sarcomas are rare cancers originating from bones, muscles, fat, and connective tissues. Unlike common carcinomas, they pose unique challenges due to their subtle symptoms—often mimicking injuries or benign lumps—and complex locations near critical structures like joints, nerves, and blood vessels. Early diagnosis is crucial, yet frequently delayed, emphasizing the need for specialized expertise.
1. Fellow in JOINT REPLACEMENT (DITO,St Parmanand Hospital, New Delhi)
2. Fellowship in Musculoskeletal Oncology, under Prof Dr ASHISH GULIA, Director & Head Surgical Oncology, Homi Bhabha Cancer Hospital & Research Centre (A unit of Tata Memorial Centre), New Chandigarh, April 2024- April 2025
Dr. Kumar brings extensive experience in managing complex trauma cases, joint replacements, and musculoskeletal tumors, including bone and soft tissue sarcomas. His subspecialty in orthopedic oncology focuses on limb salvage surgeries, advanced reconstructions, and multidisciplinary cancer care to optimize patient outcomes.
He is an active member of prestigious professional bodies, including SICOT (International Society of Orthopaedic Surgery and Traumatology), DOA (Delhi Orthopaedic Association), IOA (Indian Orthopaedic Association), MNAMS (National Academy of Medical Sciences), IMSOS (Indian Musculo-Skeletal Oncology Society), and ISOLS (International Society of Limb Salvage). These affiliations reflect his commitment to advancing orthopedic standards, research, and global collaboration in oncology.
1. Barman C, Devgan A, Malhotra M, Rohilla R, Yadav P. Evaluation of risk factors of anterior cruciate ligament (ACL) Injury: A prospective comparative analysis. Indian Journal of Orthopaedics Surgery. 2018;4(4):354-361
2. Singh, R., Kumar, P., Wadhwani, J., Yadav, R., Khanna, M. and Kaur, S., 2021. A comparative study to evaluate disc degeneration on magnetic resonance imaging in patients with chronic low back pain and asymptomatic individuals. Journal of Orthopaedics, Trauma and Rehabilitation, 28, p.221049172110395.
3. Singh R, Kumar P, Wadhwani J, Yadav RK, Kaur S, Singh HD. Do lumbar intervertebral disc parameters in patients with chronic low back pain differ quantitatively from healthy individuals? A comparative study. Journal of Orthopaedics, Trauma and Rehabilitation. 2023;30(2):169-179
4. Singh R, Kumar P, Wadhwani J, Kaur S, Singh HD. Association of the Cross-Sectional Area, Muscularity, and Muscle-Fat Ratio of the Paraspinal Muscles with Chronic Low Back Pain. J Orthop Spine Trauma 2025; 11(1): 1-10.
5. Tandon N, Kumar P, Rathore D, Sancheti S, Gulia A. Giant Cell Tumor with Chondroid Differentiation: A Case Report on This Rare Morphological Variant and a Diagnostic Challenge. Journal of Orthopaedic Case Reports 2025 November;15(11): 162-166.
Innovative techniques allow tumor removal while preserving limbs, avoiding amputation in most cases and maintaining mobility and quality of life.
Combining precision surgery with chemotherapy and targeted radiation therapies.
Expertise in managing benign and malignant bone tumors (e.g., osteosarcoma, Ewing's sarcoma, chondrosarcoma), soft tissue sarcomas, and metastatic diseases.
These progresses have dramatically improved outcomes, with survival rates rising significantly—from historically low figures to 70-80% in many cases today—thanks to better imaging, targeted drugs, and personalized care.
At our practice, we prioritize patient-centered approaches: Don’t be afraid—get informed. Persistent pain, swelling, or lumps warrant prompt specialist consultation. Bone and soft tissue sarcomas are treatable, with modern expertise offering high survival rates and active, fulfilling lives post-treatment.
Trust in specialized care—outcomes have never been better.